INR 701.25
(-2.65%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 15.53 Billion INR | 26.83% |
2022 | 12.25 Billion INR | 10.32% |
2021 | 11.1 Billion INR | -10.24% |
2020 | 12.37 Billion INR | -28.14% |
2019 | 17.21 Billion INR | -44.05% |
2018 | 30.77 Billion INR | -1.55% |
2017 | 31.25 Billion INR | -6.93% |
2016 | 33.57 Billion INR | -13.05% |
2015 | 38.62 Billion INR | -4.91% |
2014 | 40.61 Billion INR | -12.68% |
2013 | 46.51 Billion INR | 0.0% |
2011 | 39.86 Billion INR | -2.07% |
2010 | 40.7 Billion INR | 7.87% |
2009 | 37.73 Billion INR | -10.87% |
2008 | 42.33 Billion INR | 21.52% |
2007 | 34.84 Billion INR | 20.52% |
2006 | 28.91 Billion INR | 33.32% |
2005 | 21.68 Billion INR | 19.64% |
2004 | 18.12 Billion INR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q1 | - INR | -100.0% |
2023 FY | 15.53 Billion INR | 26.83% |
2023 Q2 | 14.92 Billion INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 Q4 | 15.53 Billion INR | 0.0% |
2022 Q2 | 11.65 Billion INR | 0.0% |
2022 Q4 | 12.25 Billion INR | 0.0% |
2022 FY | 12.25 Billion INR | 10.32% |
2022 Q3 | - INR | -100.0% |
2022 Q1 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 FY | 11.1 Billion INR | -10.24% |
2021 Q4 | 11.1 Billion INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q2 | 11.15 Billion INR | 0.0% |
2020 Q2 | 16.08 Billion INR | 0.0% |
2020 Q3 | - INR | -100.0% |
2020 Q4 | 12.37 Billion INR | 0.0% |
2020 FY | 12.37 Billion INR | -28.14% |
2020 Q1 | - INR | -100.0% |
2019 FY | 17.21 Billion INR | -44.05% |
2019 Q4 | 17.21 Billion INR | 0.0% |
2019 Q1 | - INR | 0.0% |
2018 FY | 30.77 Billion INR | -1.55% |
2018 Q2 | 30.35 Billion INR | 0.0% |
2017 FY | 31.25 Billion INR | -6.93% |
2016 FY | 33.57 Billion INR | -13.05% |
2015 FY | 38.62 Billion INR | -4.91% |
2014 FY | 40.61 Billion INR | -12.68% |
2013 FY | 46.51 Billion INR | 0.0% |
2013 Q2 | 46.05 Billion INR | 0.0% |
2011 FY | 39.86 Billion INR | -2.07% |
2011 Q4 | 39.86 Billion INR | 0.0% |
2010 FY | 40.7 Billion INR | 7.87% |
2009 FY | 37.73 Billion INR | -10.87% |
2008 FY | 42.33 Billion INR | 21.52% |
2007 FY | 34.84 Billion INR | 20.52% |
2006 FY | 28.91 Billion INR | 33.32% |
2005 FY | 21.68 Billion INR | 19.64% |
2004 FY | 18.12 Billion INR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Aarti Drugs Limited | 24.32 Billion INR | 36.117% |
Albert David Limited | 4.97 Billion INR | -212.028% |
Alembic Limited | 23.28 Billion INR | 33.275% |
Biofil Chemicals and Pharmaceuticals Limited | 470.82 Million INR | -3200.308% |
Hester Biosciences Limited | 6.62 Billion INR | -134.601% |
Hikal Limited | 24.87 Billion INR | 37.524% |
Ind-Swift Limited | 6.54 Billion INR | -137.424% |
Kilitch Drugs (India) Limited | 2.4 Billion INR | -547.281% |
Unichem Laboratories Limited | 31.69 Billion INR | 50.972% |
Alembic Pharmaceuticals Limited | 64.45 Billion INR | 75.892% |
Bafna Pharmaceuticals Limited | 1.47 Billion INR | -952.178% |
Bajaj HealthCare Limited | 7.65 Billion INR | -103.087% |
Brooks Laboratories Limited | 904.45 Million INR | -1618.024% |
Eris Lifesciences Limited | 70.48 Billion INR | 77.956% |
Solara Active Pharma Sciences Limited | 23.46 Billion INR | 33.782% |
Jagsonpal Pharmaceuticals Limited | 2.17 Billion INR | -615.814% |
Wanbury Limited | 3.43 Billion INR | -352.374% |
Aarti Pharmalabs Limited | 25.82 Billion INR | 39.821% |
Alkem Laboratories Limited | 155.74 Billion INR | 90.023% |
FDC Limited | 24.68 Billion INR | 37.041% |
Glenmark Life Sciences Limited | 28.5 Billion INR | 45.486% |
Gufic Biosciences Limited | 10.92 Billion INR | -42.226% |
Ind-Swift Laboratories Limited | 11.65 Billion INR | -33.368% |
Innova Captab Limited | 13.2 Billion INR | -17.639% |
IOL Chemicals and Pharmaceuticals Limited | 22.44 Billion INR | 30.767% |
Ipca Laboratories Limited | 111.01 Billion INR | 86.003% |
Jubilant Pharmova Limited | 115.48 Billion INR | 86.545% |
Lincoln Pharmaceuticals Limited | 7 Billion INR | -121.89% |
Lupin Limited | 239.97 Billion INR | 93.525% |
Mangalam Drugs & Organics Limited | 3.33 Billion INR | -366.035% |
Medico Remedies Limited | 961.95 Million INR | -1515.332% |
Morepen Laboratories Limited | 12.93 Billion INR | -20.157% |
Nectar Lifesciences Limited | 21.91 Billion INR | 29.081% |
Procter & Gamble Health Limited | 7.94 Billion INR | -95.613% |
RPG Life Sciences Limited | 5.12 Billion INR | -202.976% |
Sigachi Industries Limited | 6.94 Billion INR | -123.851% |
Sun Pharmaceutical Industries Limited | 854.62 Billion INR | 98.182% |
Suven Pharmaceuticals Limited | 22.54 Billion INR | 31.064% |
Themis Medicare Limited | 5.66 Billion INR | -174.334% |
Vaishali Pharma Limited | 799.55 Million INR | -1843.419% |
Venus Remedies Limited | 6.26 Billion INR | -147.894% |
Windlas Biotech Limited | 6.26 Billion INR | -148.141% |
ZIM Laboratories Limited | 4.46 Billion INR | -247.761% |
Sakar Healthcare Limited | 3.88 Billion INR | -299.804% |
Aurobindo Pharma Limited | 450.71 Billion INR | 96.552% |
Divi's Laboratories Limited | 154.7 Billion INR | 89.956% |
AstraZeneca Pharma India Limited | 10.78 Billion INR | -44.14% |
Mankind Pharma Limited | 119.63 Billion INR | 87.011% |
Sequent Scientific Limited | 15.4 Billion INR | -0.876% |
Laurus Labs Limited | 83.87 Billion INR | 81.473% |
Neuland Laboratories Limited | 18.32 Billion INR | 15.208% |
J. B. Chemicals & Pharmaceuticals Limited | 39.94 Billion INR | 61.096% |
Glenmark Pharmaceuticals Limited | 143.58 Billion INR | 89.178% |
Zydus Lifesciences Limited | 292.8 Billion INR | 94.693% |
Amrutanjan Health Care Limited | 3.66 Billion INR | -323.548% |
Wockhardt Limited | 76.49 Billion INR | 79.685% |
Bal Pharma Limited | 3.2 Billion INR | -384.996% |
Dr. Reddy's Laboratories Limited | 387.51 Billion INR | 95.99% |
Bliss GVS Pharma Limited | 12.13 Billion INR | -28.01% |
Par Drugs and Chemicals Limited | 1.01 Billion INR | -1429.236% |
Caplin Point Laboratories Limited | 26.97 Billion INR | 42.393% |
Shilpa Medicare Limited | 30.93 Billion INR | 49.765% |
Valiant Laboratories Limited | 3.42 Billion INR | -353.438% |
Ajanta Pharma Limited | 46.38 Billion INR | 66.5% |
Aarey Drugs & Pharmaceuticals Limited | 3.04 Billion INR | -409.48% |
Granules India Limited | 55.2 Billion INR | 71.855% |
Medicamen Biotech Limited | 2.94 Billion INR | -427.591% |
Syncom Formulations (India) Limited | 4.04 Billion INR | -283.991% |
Piramal Enterprises Limited | 826.05 Billion INR | 98.119% |
Torrent Pharmaceuticals Limited | 150.61 Billion INR | 89.683% |
NATCO Pharma Limited | 69.06 Billion INR | 77.501% |
Suven Life Sciences Limited | 2.84 Billion INR | -445.405% |
Krebs Biochemicals & Industries Limited | 1.78 Billion INR | -772.107% |
Strides Pharma Science Limited | 58.39 Billion INR | 73.391% |
Indoco Remedies Limited | 21.44 Billion INR | 27.549% |
Alpa Laboratories Limited | 1.82 Billion INR | -750.87% |
Lasa Supergenerics Limited | 1.5 Billion INR | -929.951% |
Sun Pharma Advanced Research Company Limited | 5.15 Billion INR | -201.7% |